T

TRDA

TRDA

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
5%Bearish
Buy/Sell Ratio11% buys
BearishBullish
TRDA Live QuoteReal-time
$4.64
$0.01(-0.22%)1M
Day Range$4.59 – $5.34
Open$5.02
Previous Close$5.03
Volume341.1K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$196.93M
P/E Ratio (TTM)24.5
Forward P/E3333.3
EPS (TTM)$-3.84
Price to Book1.0
Dividend Yield0.65%
Beta (Volatility)-0.15
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $4.64 (4%)
Low: $4.11High: $16.45
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$17.75-88.2% upside

Insider Buys

4

$2.38M

Insider Sales

33

$20.13M

Total Volume

$22.51M

37 transactions

Net Activity

$17.75M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
55CONFIDENCE

Sentiment Rating

Neutral / Balanced

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Heavy distribution: sales represent 89% of total transaction value.
  • •Cluster buying: 3 unique insiders purchased shares, showing strong alignment.
  • •High accumulation: total purchase value exceeds $1M.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
P
1

Parmar Kush

Dir

0 buys5 sells

$4.72M total

M
2

Mpm Bioventures 2018, L.P.

10%

0 buys5 sells

$4.52M total

M
3

Mpm Bioventures 2014, L.P.

10%

0 buys5 sells

$4.52M total

5
4

5Am Ventures V, L.P.

10%

0 buys5 sells

$4.07M total

B
5

Baker Bros. Advisors LP

10%

2 buys0 sells

$1.61M total

Trading History
TRDA insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 4, 2026

2 months ago

Mpm Bioventures 2018, L.P.

10%

10% Owner
Sell259.8K$7.33$1.91M

Sep 4, 2026

2 months ago

Mpm Bioventures 2014, L.P.

10%

10% Owner
Sell259.8K$7.33$1.91M

Sep 1, 2026

2 months ago

Mpm Bioventures 2018, L.P.

10%

10% Owner
Sell86.5K$7.14$617K

Sep 1, 2026

2 months ago

Mpm Bioventures 2014, L.P.

10%

10% Owner
Sell86.5K$7.14$617K

Aug 27, 2026

2 months ago

Mpm Bioventures 2018, L.P.

10%

10% Owner
Sell86.9K$7.08$616K

Aug 27, 2026

2 months ago

Mpm Bioventures 2014, L.P.

10%

10% Owner
Sell86.9K$7.08$616K

Aug 24, 2026

2 months ago

Mpm Bioventures 2014, L.P.

10%

10% Owner
Sell62.7K$7.36$462K

Aug 24, 2026

2 months ago

Mpm Bioventures 2018, L.P.

10%

10% Owner
Sell62.7K$7.36$462K

Aug 6, 2026

3 months ago

Parmar Kush

Dir

Director
Sell155.3K$6.95$1.08M

Aug 6, 2026

3 months ago

5Am Ventures V, L.P.

10%

10% Owner
Sell62.8K$6.88$432K

Jul 30, 2026

3 months ago

5Am Ventures V, L.P.

10%

10% Owner
Sell116.5K$6.93$807K

Jul 30, 2026

3 months ago

Parmar Kush

Dir, 10%

Director
Sell116.5K$6.93$807K

May 20, 2026

6 months ago

Zeiher Bernhardt G

Dir

Director
Buy5.0K$5.86$29K

May 4, 2026

6 months ago

Sethuraman Natarajan

Pres, Research, Develop.

President
Sell25.9K$15.39$399K

May 4, 2026

6 months ago

Dowden Nathan J

Pres, COO

COO
Sell15.0K$15.33$230K

Apr 1, 2026

7 months ago

Wentworth Kory James

CFO

CFO
Sell2.5K$12.95$32K

Mar 9, 2026

8 months ago

Dowden Nathan J

Pres, COO

COO
Sell15.0K$13.04$196K

Mar 9, 2026

8 months ago

Wentworth Kory James

CFO

CFO
Sell16.5K$13.01$214K

Mar 4, 2026

8 months ago

Wentworth Kory James

CFO

CFO
Sell8.0K$12.25$98K

Nov 21, 2025

12 months ago

Wentworth Kory James

CFO

CFO
Sell8.9K$9.98$89K

Nov 20, 2025

12 months ago

Baker Bros. Advisors LP

10%

10% Owner
Buy28.9K$9.07$262K

Nov 14, 2025

12 months ago

Parmar Kush

Dir, 10%

Director
Sell200.0K$8.80$1.76M

Nov 14, 2025

12 months ago

5Am Ventures V, L.P.

10%

10% Owner
Sell200.0K$8.80$1.76M

Nov 10, 2025

12 months ago

Baker Bros. Advisors LP

10%

10% Owner
Buy178.0K$7.60$1.35M

Jul 9, 2025

16 months ago

Parmar Kush

Dir, 10%

Director
Sell27.0K$7.50$203K

Jul 9, 2025

16 months ago

5Am Ventures V, L.P.

10%

10% Owner
Sell27.0K$7.50$203K

Jun 27, 2025

17 months ago

Parmar Kush

Dir, 10%

Director
Sell125.0K$6.93$867K

Jun 27, 2025

17 months ago

5Am Ventures V, L.P.

10%

10% Owner
Sell125.0K$6.93$867K

May 13, 2024

30 months ago

Kim Peter S

Dir

Director
Buy50.0K$14.63$732K

Mar 17, 2025

20 months ago

Wentworth Kory James

CFO

CFO
Sell1.8K$10.67$19K

Dec 10, 2024

23 months ago

Mpm Bioventures 2018, L.P.

10%

10% Owner
Sell44.7K$20.51$917K

Dec 10, 2024

23 months ago

Mpm Bioventures 2014, L.P.

10%

10% Owner
Sell44.7K$20.51$917K

Nov 29, 2024

24 months ago

Wentworth Kory James

CFO

CFO
Sell6.0K$19.99$120K

Nov 29, 2024

24 months ago

Sethuraman Natarajan

Pres, Research, Develop.

President
Sell15.9K$20.18$321K

Nov 11, 2024

24 months ago

Sethuraman Natarajan

Pres, Research, Develop.

President
Sell4.1K$20.03$82K

Nov 11, 2024

24 months ago

Wentworth Kory James

CFO

CFO
Sell8.6K$19.98$173K

Nov 4, 2024

24 months ago

Sethuraman Natarajan

Pres, Research, Develop.

President
Sell18.2K$18.62$339K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
TRDA Buy Conviction11%
Industry Rank#0 of 569
Volume Contribution0.1%
Total Industry Activity$16.53B

TRDA has an insider buy conviction of 11%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for TRDA

Over the last 90 days, corporate insiders at TRDA (TRDA) engaged in a total of 37 transactions reported via SEC Form 4 filings. Among these, 4 were open-market purchases and 33 were sales. The total volume of insider trading reached $22.51M.

The net insider activity for TRDA shows a net selling bias of $17.75M. This activity represents a 11% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Mpm Bioventures 2018, L.P. (10%), who traded 259.8K shares valued at $1.91M on Sep 4, 2026.

Live Market News & Developments
Aggregated real-time headlines for TRDA (TRDA)
6 updates

Entrada Therapeutics, Inc. (TRDA) Stock Price, News, Quote & History

Yahoo! Finance CanadaYesterday

New Analyst Forecast: $TRDA Given $13 Price Target

Quiver QuantitativeYesterday

A rare muscle-disease drug candidate is designed for one dose every six weeks.

Stock Titan2d ago

The Technical Signals Behind (TRDA) That Institutions Follow

Stock Traders DailyYesterday

TRDA - Entrada Therapeutics Inc Stock Price and Quote

Finviz177d ago

Entrada Therapeutics: Weak Dystrophin Data May Be Creating A Buying Opportunity

Seeking Alpha41d ago

FAQs About TRDA Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for TRDA.

Based on SEC Form 4 disclosures, the Insider Confidence Score for TRDA is currently 55/100, which reflects a neutral / balanced bias. This calculation accounts for a total of 4 purchases and 33 sales by company executives over the last 90 days.

The CEO Conviction Index for TRDA is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.